Qynapse is thrilled to be part of the Scientific Program of AAIC and the Virtual Exhibition from July 27 to July 31 − to present our latest advances and solutions.
QyScore® allows automated quantification of a broad portfolio of Magnetic Resonance Imaging markers that are key to support early diagnosis and clinical monitoring of neurodegenerative disorders
QyScore®, the software by Qynapse that provides automated volumetric measurements of brain structures, takes a big step forward with the validation of performance for one of its major functionalities
Qynapse is pleased to announce the signing of a partnership agreement with AG Mednet, the leading provider of medical trials data management services, for the use of its Judi imaging adjudication system
On September 20th 2018, Qynapse was featured on the evening news program of the French network France 3 in a report dedicated to Alzheimer’s disease diagnosis
Qynapse was featured in the 2018 selection of the “Top 100 start-ups where to invest”
in the French business magazine Challenges
Qynapse is a medical technology company that unlocks the potential of quantitative imaging and AI to optimize diagnosis, prognosis and longitudinal monitoring of patients with neurological diseases.
- Qynapse is pleased to sponsor #ACTRIMSForum 2021 – established to advance the research and clinical care of multipl… https://t.co/KJPuq7p83I13 hours ago
- As a founding member of the Decentralized Trials & Research Alliance @DTRAorg, we look forward to the collaboration… https://t.co/MkPrmyZmiu30 days ago
- Qynapse wishes you a Happy New Year 2021! We look forward to continue with exciting collaborations this year – to d… https://t.co/fMjDxQFUq851 days ago
- By advancing #decentralizedtrials we can make clinical trials more patient-focused, diverse and efficient, and leve… https://t.co/z8ck93CH7Y56 days ago
130, rue de Lourmel
75015 Paris – France